{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:27:25Z","timestamp":1793460445300,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"crossref","award":["DP150101715"],"award-info":[{"award-number":["DP150101715"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington\u2019s disease (HD) is an autosomal dominant neurodegenerative illness caused by a mutation in the huntingtin gene (HTT) and subsequent protein (mhtt), to which the brain shows a region-specific vulnerability. Disturbances in neural cholesterol metabolism are established in HD human, murine and cell studies; however, cholesteryl esters (CE), which store and transport cholesterol in the brain, have not been investigated in human studies. This study aimed to identify region-specific alterations in the concentrations of CE in HD. The Victorian Brain Bank provided post-mortem tissue from 13 HD subjects and 13 age and sex-matched controls. Lipids were extracted from the caudate, putamen and cerebellum, and CE were quantified using targeted mass spectrometry. ACAT 1 protein expression was measured by western blot. CE concentrations were elevated in HD caudate and putamen compared to controls, with the elevation more pronounced in the caudate. No differences in the expression of ACAT1 were identified in the striatum. No remarkable differences in CE were detected in HD cerebellum. The striatal region-specific differences in CE profiles indicate functional subareas of lipid disturbance in HD. The increased CE concentration may have been induced as a compensatory mechanism to reduce cholesterol accumulation.<\/jats:p>","DOI":"10.1038\/s41598-020-76973-8","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T11:11:54Z","timestamp":1605870714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Cholesteryl ester levels are elevated in the caudate and putamen of Huntington\u2019s disease patients"],"prefix":"10.1038","volume":"10","author":[{"given":"Gabrielle R.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon H. J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kreilaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"76973_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","volume":"4","author":"RC Block","year":"2010","unstructured":"Block, R. C., Dorsey, E. R., Beck, C. A., Brenna, J. T. & Shoulson, I. Altered cholesterol and fatty acid metabolism in Huntington disease. J. Clin. Lipidol. 4, 17\u201323 (2010).","journal-title":"J. Clin. Lipidol."},{"key":"76973_CR2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross, C. A. et al. Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 10, 204\u2013216 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"76973_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41593-018-0075-7","volume":"21","author":"MB Victor","year":"2018","unstructured":"Victor, M. B. et al. Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat. Neurosci. 21, 341\u2013352 (2018).","journal-title":"Nat. Neurosci."},{"key":"76973_CR4","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.bbamem.2013.04.025","volume":"1828","author":"KA Burke","year":"2013","unstructured":"Burke, K. A., Hensal, K. M., Umbaugh, C. S., Chaibva, M. & Legleiter, J. Huntingtin disrupts lipid bilayers in a polyQ-length dependent manner. Biochim. Biophys. Acta BBA Biomembr. 1828, 1953\u20131961 (2013).","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"76973_CR5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.neuro.25.112701.142937","volume":"25","author":"MG Packard","year":"2002","unstructured":"Packard, M. G. & Knowlton, B. J. Learning and memory functions of the basal ganglia. Annu. Rev. Neurosci. 25, 563\u2013593 (2002).","journal-title":"Annu. Rev. Neurosci."},{"key":"76973_CR6","doi-asserted-by":"crossref","unstructured":"B\u00e1ez-Mendoza, R. & Schultz, W. The role of the striatum in social behavior. Front. Neurosci. 7, 233 (2013).","DOI":"10.3389\/fnins.2013.00233"},{"key":"76973_CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/nan.12286","volume":"42","author":"F Kreilaus","year":"2016","unstructured":"Kreilaus, F., Spiro, A. S., McLean, C. A., Garner, B. & Jenner, A. M. Evidence for altered cholesterol metabolism in Huntington\u2019s disease post mortem brain tissue: Altered cholesterol metabolism in Huntington\u2019s disease. Neuropathol. Appl. Neurobiol. 42, 535\u2013546 (2016).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"76973_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin, R. L., Young, A. B. & Penney, J. B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366\u2013375 (1989).","journal-title":"Trends Neurosci."},{"key":"76973_CR9","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.bbamem.2009.08.016","volume":"1788","author":"J Fantini","year":"2009","unstructured":"Fantini, J. & Barrantes, F. J. Sphingolipid\/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim. Biophys. Acta BBA Biomembr. 1788, 2345\u20132361 (2009).","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"76973_CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","volume":"28","author":"M Valenza","year":"2007","unstructured":"Valenza, M. et al. Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol. Dis. 28, 133\u2013142 (2007).","journal-title":"Neurobiol. Dis."},{"key":"76973_CR11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2007.10.002","volume":"93","author":"M Markianos","year":"2008","unstructured":"Markianos, M., Panas, M., Kalfakis, N. & Vassilopoulos, D. Low plasma total cholesterol in patients with Huntington\u2019s disease and first-degree relatives. Mol. Genet. Metab. 93, 341\u2013346 (2008).","journal-title":"Mol. Genet. Metab."},{"key":"76973_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pneurobio.2006.09.005","volume":"80","author":"M Valenza","year":"2006","unstructured":"Valenza, M. & Cattaneo, E. Cholesterol dysfunction in neurodegenerative diseases: Is Huntington\u2019s disease in the list?. Prog. Neurobiol. 80, 165\u2013176 (2006).","journal-title":"Prog. Neurobiol."},{"key":"76973_CR13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang, J. & Liu, Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell 6, 254\u2013264 (2015).","journal-title":"Protein Cell"},{"key":"76973_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mcn.2009.07.013","volume":"43","author":"J-P Liu","year":"2010","unstructured":"Liu, J.-P. et al. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol. Cell. Neurosci. 43, 33\u201342 (2010).","journal-title":"Mol. Cell. Neurosci."},{"key":"76973_CR15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3233\/JHD-150170","volume":"4","author":"F Kreilaus","year":"2015","unstructured":"Kreilaus, F., Spiro, A. S., Hannan, A. J., Garner, B. & Jenner, A. M. Brain cholesterol synthesis and metabolism is progressively disturbed in the R6\/1 mouse model of Huntington\u2019s disease: A targeted GC-MS\/MS sterol analysis. J. Huntington\u2019s Dis. 4, 305\u2013318 (2015).","journal-title":"J. Huntington\u2019s Dis."},{"key":"76973_CR16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.plipres.2010.03.003","volume":"49","author":"S Gulati","year":"2010","unstructured":"Gulati, S., Liu, Y., Munkacsi, A. B., Wilcox, L. & Sturley, S. L. Sterols and sphingolipids: Dynamic duo or partners in crime?. Prog. Lipid Res. 49, 353\u2013365 (2010).","journal-title":"Prog. Lipid Res."},{"key":"76973_CR17","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza, M. Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J. Neurosci. 25, 9932\u20139939 (2005).","journal-title":"J. Neurosci."},{"key":"76973_CR18","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","volume":"131","author":"V Leoni","year":"2008","unstructured":"Leoni, V. et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease. Brain 131, 2851\u20132859 (2008).","journal-title":"Brain"},{"key":"76973_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2016.11.013","volume":"98","author":"M Shankaran","year":"2017","unstructured":"Shankaran, M. et al. Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington\u2019s disease: A cross-validation study in Q175 knock-in mice. Neurobiol. Dis. 98, 66\u201376 (2017).","journal-title":"Neurobiol. Dis."},{"key":"76973_CR20","doi-asserted-by":"crossref","first-page":"e0134465","DOI":"10.1371\/journal.pone.0134465","volume":"10","author":"JB Carroll","year":"2015","unstructured":"Carroll, J. B. et al. HdhQ111 mice exhibit tissue specific metabolite profiles that include striatal lipid accumulation. PLoS ONE 10, e0134465 (2015).","journal-title":"PLoS ONE"},{"key":"76973_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2013.03.013","volume":"55","author":"V Leoni","year":"2013","unstructured":"Leoni, V., Long, J. D., Mills, J. A., Di Donato, S. & Paulsen, J. S. Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression. Neurobiol. Dis. 55, 37\u201343 (2013).","journal-title":"Neurobiol. Dis."},{"key":"76973_CR22","doi-asserted-by":"crossref","first-page":"35132","DOI":"10.1074\/jbc.273.52.35132","volume":"273","author":"CCY Chang","year":"1998","unstructured":"Chang, C. C. Y. et al. Recombinant acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) purified to essential homogeneity utilizes cholesterol in mixed micelles or in vesicles in a highly cooperative manner. J. Biol. Chem. 273, 35132\u201335141 (1998).","journal-title":"J. Biol. Chem."},{"key":"76973_CR23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2011.04.018","volume":"185","author":"J-H Kim","year":"2011","unstructured":"Kim, J.-H. et al. Increased expression of acyl-coenzyme A: Cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury. Neuroscience 185, 125\u2013134 (2011).","journal-title":"Neuroscience"},{"key":"76973_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-510X(86)90190-5","volume":"74","author":"ASL Pitk\u00e4nen","year":"1986","unstructured":"Pitk\u00e4nen, A. S. L., Halonen, T. O., Kilpel\u00e4inen, H. O. & Riekkinen, P. J. Cholesterol esterase activity in cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. 74, 45\u201353 (1986).","journal-title":"J. Neurol. Sci."},{"key":"76973_CR25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.10312","volume":"52","author":"RG Cutler","year":"2002","unstructured":"Cutler, R. G., Pedersen, W. A., Camandola, S., Rothstein, J. D. & Mattson, M. P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 52, 448\u2013457 (2002).","journal-title":"Ann. Neurol."},{"key":"76973_CR26","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.0913828107","volume":"107","author":"EY Bryleva","year":"2010","unstructured":"Bryleva, E. Y. et al. ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proc. Natl. Acad. Sci. 107, 3081\u20133086 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"76973_CR27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1515\/hsz-2014-0310","volume":"396","author":"W-J Park","year":"2015","unstructured":"Park, W.-J. & Park, J.-W. The effect of altered sphingolipid acyl chain length on various disease models. Biol. Chem. 396, 693\u2013705 (2015).","journal-title":"Biol. Chem."},{"key":"76973_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","volume":"51","author":"S Gr\u00f6sch","year":"2012","unstructured":"Gr\u00f6sch, S., Schiffmann, S. & Geisslinger, G. Chain length-specific properties of ceramides. Prog. Lipid Res. 51, 50\u201362 (2012).","journal-title":"Prog. Lipid Res."},{"key":"76973_CR29","doi-asserted-by":"crossref","unstructured":"Tracey, T. J., Steyn, F. J., Wolvetang, E. J. & Ngo, S. T. Neuronal lipid metabolism: Multiple pathways driving functional outcomes in health and disease. Front. Mol. Neurosci. 11, 10 (2018).","DOI":"10.3389\/fnmol.2018.00010"},{"key":"76973_CR30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajhg.2015.12.018","volume":"98","author":"JW Keum","year":"2016","unstructured":"Keum, J. W. et al. The HTT CAG-expansion mutation determines age at death but not disease duration in huntington disease. Am. J. Hum. Genet. 98, 287\u2013298 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"76973_CR31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.32607\/20758251-2016-8-1-58-73","volume":"8","author":"AM Petrov","year":"2016","unstructured":"Petrov, A. M., Kasimov, M. R. & Zefirov, A. L. Brain cholesterol metabolism and its defects: Linkage to neurodegenerative diseases and synaptic dysfunction. Acta Nat. 8, 58\u201373 (2016).","journal-title":"Acta Nat."},{"key":"76973_CR32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41586-020-2290-0","volume":"581","author":"H Qian","year":"2020","unstructured":"Qian, H. et al. Structural basis for catalysis and substrate specificity of human ACAT1. Nature 581, 333\u2013338 (2020).","journal-title":"Nature"},{"key":"76973_CR33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0014-4886(80)90114-4","volume":"68","author":"SN Shah","year":"1980","unstructured":"Shah, S. N. & Johnson, R. C. Activity levels of cholesterol ester metabolizing enzymes in brain in multiple sclerosis: Correlation with cholesterol ester concentrations. Exp. Neurol. 68, 601\u2013604 (1980).","journal-title":"Exp. Neurol."},{"key":"76973_CR34","doi-asserted-by":"crossref","first-page":"e24777","DOI":"10.1371\/journal.pone.0024777","volume":"6","author":"G Astarita","year":"2011","unstructured":"Astarita, G. et al. Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer\u2019s disease. PLoS ONE 6, e24777 (2011).","journal-title":"PLoS ONE"},{"key":"76973_CR35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuron.2004.08.043","volume":"44","author":"B Hutter-Paier","year":"2004","unstructured":"Hutter-Paier, B. et al. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer\u2019s disease. Neuron 44, 227\u2013238 (2004).","journal-title":"Neuron"},{"key":"76973_CR36","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.4155\/fmc.15.161","volume":"7","author":"Y Shibuya","year":"2015","unstructured":"Shibuya, Y., Chang, C. C. & Chang, T.-Y. ACAT1\/SOAT1 as a therapeutic target for Alzheimer\u2019s disease. Future Med. Chem. 7, 2451\u20132467 (2015).","journal-title":"Future Med. Chem."},{"key":"76973_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2017.05.042","author":"J Bourbon-Teles","year":"2017","unstructured":"Bourbon-Teles, J. et al. Myelin breakdown in human Huntington\u2019s disease: Multi-modal evidence from diffusion MRI and quantitative magnetization transfer. Neuroscience https:\/\/doi.org\/10.1016\/j.neuroscience.2017.05.042 (2017).","journal-title":"Neuroscience"},{"key":"76973_CR38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1471-4159.1969.tb06453.x","volume":"16","author":"C Alling","year":"1969","unstructured":"Alling, C. & Svennerholm, L. Concentration and fatty acid composition of cholesteryl esters of normal human brain. J. Neurochem. 16, 751\u2013759 (1969).","journal-title":"J. Neurochem."},{"key":"76973_CR39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainresbull.2006.10.028","volume":"72","author":"EH Aylward","year":"2007","unstructured":"Aylward, E. H. Change in MRI striatal volumes as a biomarker in preclinical Huntington\u2019s disease. Brain Res. Bull. 72, 152\u2013158 (2007).","journal-title":"Brain Res. Bull."},{"key":"76973_CR40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","volume":"63","author":"EH Aylward","year":"2004","unstructured":"Aylward, E. H. et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63, 66\u201372 (2004).","journal-title":"Neurology"},{"key":"76973_CR41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel, J. P. et al. Neuropathological classification of Huntington\u2019s disease. J. Neuropathol. Exp. Neurol. 44, 559\u2013577 (1985).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"76973_CR42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/exnr.1998.6919","volume":"154","author":"GM Halliday","year":"1998","unstructured":"Halliday, G. M. et al. Regional specificity of brain atrophy in Huntington\u2019s disease. Exp. Neurol. 154, 663\u2013672 (1998).","journal-title":"Exp. Neurol."},{"key":"76973_CR43","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1471-4159.2010.06964.x","volume":"115","author":"CA Denny","year":"2010","unstructured":"Denny, C. A., Desplats, P. A., Thomas, E. A. & Seyfried, T. N. Cerebellar lipid differences between R6\/1 transgenic mice and humans with Huntington\u2019s disease: Cerebellar lipids in Huntington\u2019s disease. J. Neurochem. 115, 748\u2013758 (2010).","journal-title":"J. Neurochem."},{"key":"76973_CR44","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1093\/hmg\/ddr355","volume":"20","author":"E Fossale","year":"2011","unstructured":"Fossale, E. et al. Differential effects of the Huntington\u2019s disease CAG mutation in striatum and cerebellum are quantitative not qualitative. Hum. Mol. Genet. 20, 4258\u20134267 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"76973_CR45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.25413","volume":"85","author":"MK Singh-Bains","year":"2019","unstructured":"Singh-Bains, M. K. et al. Cerebellar degeneration correlates with motor symptoms in Huntington disease. Ann. Neurol. 85, 396\u2013405 (2019).","journal-title":"Ann. Neurol."},{"key":"76973_CR46","first-page":"1095","volume":"1851","author":"V Leoni","year":"2015","unstructured":"Leoni, V. & Caccia, C. The impairment of cholesterol metabolism in Huntington disease. Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids 1851, 1095\u20131105 (2015).","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids"},{"key":"76973_CR47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","volume":"5","author":"J Fern\u00f8","year":"2005","unstructured":"Fern\u00f8, J. et al. Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: A novel mechanism of action?. Pharmacogenom. J. 5, 298\u2013304 (2005).","journal-title":"Pharmacogenom. J."},{"key":"76973_CR48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neulet.2005.10.096","volume":"395","author":"MB Raeder","year":"2006","unstructured":"Raeder, M. B., Fern\u00f8, J., Glambek, M., Stansberg, C. & Steen, V. M. Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci. Lett. 395, 185\u2013190 (2006).","journal-title":"Neurosci. Lett."},{"key":"76973_CR49","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1017\/S146114570900995X","volume":"12","author":"LH-W Lee","year":"2009","unstructured":"Lee, L.H.-W. et al. Lipidomic analyses of the mouse brain after antidepressant treatment: Evidence for endogenous release of long-chain fatty acids?. Int. J. Neuropsychopharmacol. 12, 953\u2013964 (2009).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"76973_CR50","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137\u20131146 (2008).","journal-title":"J. Lipid Res."},{"key":"76973_CR51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11745-013-3760-z","volume":"48","author":"SK Abbott","year":"2013","unstructured":"Abbott, S. K. et al. An improved high-throughput lipid extraction method for the analysis of human brain lipids. Lipids 48, 307\u2013318 (2013).","journal-title":"Lipids"},{"key":"76973_CR52","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.neurobiolaging.2015.01.002","volume":"36","author":"SE Norris","year":"2015","unstructured":"Norris, S. E., Friedrich, M. G., Mitchell, T. W., Truscott, R. J. W. & Else, P. L. Human prefrontal cortex phospholipids containing docosahexaenoic acid increase during normal adult aging, whereas those containing arachidonic acid decrease. Neurobiol. Aging 36, 1659\u20131669 (2015).","journal-title":"Neurobiol. Aging"},{"key":"76973_CR53","doi-asserted-by":"crossref","unstructured":"Tran, P. N. et al. A female gametocyte-specific ABC transporter plays a role in lipid metabolism in the malaria parasite. Nat. Commun. 5, 4773 (2014).","DOI":"10.1038\/ncomms5773"},{"key":"76973_CR54","first-page":"288","volume":"1781","author":"JM Deeley","year":"2008","unstructured":"Deeley, J. M. et al. Human lens lipids differ markedly from those of commonly used experimental animals. Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids 1781, 288\u2013298 (2008).","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76973-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:46:21Z","timestamp":1670370381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76973-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76973"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76973-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20314"}}